Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

MLA

Cuerq, Charlotte, et al. “Efficacy of Two Vitamin E Formulations in Patients with Abetalipoproteinemia and Chylomicron Retention Disease.” Journal of Lipid Research, vol. 59, no. 9, Sept. 2018, pp. 1640–48. EBSCOhost, https://doi.org/10.1194/jlr.M085043.

APA

Cuerq, C., Henin, E., Restier, L., Blond, E., Drai, J., Marçais, C., Di Filippo, M., Laveille, C., Michalski, M.-C., Poinsot, P., Caussy, C., Sassolas, A., Moulin, P., Reboul, E., Charriere, S., Levy, E., Lachaux, A., & Peretti, N. (2018). Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease. Journal of Lipid Research, 59(9), 1640–1648. https://doi.org/10.1194/jlr.M085043

Chicago

Cuerq, Charlotte, Emilie Henin, Lioara Restier, Emilie Blond, Jocelyne Drai, Christophe Marçais, Mathilde Di Filippo, et al. 2018. “Efficacy of Two Vitamin E Formulations in Patients with Abetalipoproteinemia and Chylomicron Retention Disease.” Journal of Lipid Research 59 (9): 1640–48. doi:10.1194/jlr.M085043.